New diabetes clinical trial: A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Published on: October 01, 2024 at 11:00PM
Conditions: Mesothelin Positive; Mesothelin-Expressing Tumors; Esophageal Adenocarcinoma; Esophageal Adenocarcinomas; Esophagogastric Adenocarcinoma; Peritoneal Carcinomatosis; Breast Neoplasms; Diabetes Mellitus
Interventions: Biological: M28z1XXPD1DNR CAR
Sponsors: Memorial Sloan Kettering Cancer Center
Recruiting
https://ift.tt/h0m8kVY